News zum Sektor Gesundheit aus Afrika

 

Die Hilfsorganisation will wachrütteln: Vor allem nichtarabische Bevölkerungsgruppen seien Opfer "unvorstellbarer Brutalität". Die Täter kämen oft aus den Reihen der RSF-Miliz....

The tragic toll of Sudan's destroyed healthcare...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

Africa's largest drugmaker expects to get approval in Canada for its generic GLP-1 obesity treatment by September, potentially giving it an early start in a key market after Novo Nordisk A/S's Ozempic patent expired....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Several private credit heavyweights are set to join Australia private equity firm BGH Capital Pty.'s A$1.4 billion ($976 million) loan backing its acquisition of Aspen Pharmacare Holdings Ltd.'s Asia Pacific operations, according to people familiar with the matter....

PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology, which measures the electrical conductivity of tissues in real time at the local level to secure and simplify the placement of bone implants, today announced its revenue for the fiscal year ended December 31, 2025. Pierre Jérôme, Chairman, CEO and co-founder of SpineGuard, said: " The actions taken in 2025 to adapt our cost structure, particularly in the United States, significantly improved our operating performance, while having a temporary downward impact on our revenue. The growth recorded in Europe and Asia, as well as the sequential increase in our overall revenue in the fourth quarter, demonstrate the resilience of our model. The settlement of our main debt is a key milestone that will facilitate the finalization of the sale of our US subsidiary to Omnia Medical, our US partner, which is set to launch its new sacroi...

Indian pharmaceutical exports are experiencing robust growth in emerging markets like Brazil and Nigeria, driven by increased healthcare access and demand for generics. Despite global economic headwinds, these nations are becoming crucial destinations, contributing significantly to India's overall pharma export expansion and strengthening its global market position....

Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium Markets...

ANI Pharmaceuticals' shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight momentum in rare diseases....

Oddity Tech has kept up its momentum since coming public in 2023 and is aiming to revolutionize the beauty industry....

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

Novo Nordisk shares jump after the U.S. launch of its FDA-approved Wegovy pill, giving the first oral GLP-1 weight-loss drug a chance to revive 2026 momentum....

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk....

Ethics Questions Swirl Around Somalia's UN Ambassador Tied To Ohio Healthcare Company Somalia's Permanent Representative to the United Nations, Abukar Dahir Osman, is facing growing scrutiny over his connections to the Ohio healthcare company Progressive Health Care Services Inc. This comes as federal investigations into suspected Somali-linked welfare fraud, stretching from Minnesota to Washington, Ohio, and Maine, continue to intensify, with allegations that some entities (daycares, healthcare, or transportation service companies) were merely front operations to extract taxpayer funds. The most entertainingly ironic outcome is the most likely — Elon Musk (@elonmusk) January 1, 2026 The story surrounding Osman is certainly a strange one, with the news and analysis outlet Horn Diplomat publishing a report titled "Ethics Questions Surround Somalia's UN Envoy, as U.S. Healthcare Fraud Scandals Heighten Scrutiny." Here's the report: Public corporate filings and professional reco...